Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts.
Now here’s the best of what YOU had to say:
- Stem cell primer offers little to advance facelifts. “Stem cells facelifts are a marketing scheme (IMHO) which are promising results that haven’t been studied.”
- Harvard stem cell research reveals reprogramming gene. “An interdisciplinary group of Harvard scientists stumbled across a new mechanism involved in the reprogramming of stem cells that could help “fine tune” induced pluripotent stem cells into specific cell types.”
- Ahuja Medical Center open house Nov. 14. “Northeast Ohio’s newest full-service hospital will begin treating patients early next year.”
- Stryker Biotech spars with prosecutors over criminal charges. “Federal prosecutors last month declined to produce evidence the defendants claimed could clear them of the charges. Now they’re ripping into the defendants’ arguments, filed in September, that 12 of the 16 charges should be dismissed.”
